SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-002000
Filing Date
2019-01-04
Accepted
2019-01-04 09:04:37
Documents
10
Period of Report
2019-01-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d674389d8k.htm 8-K 42157
2 EX-2.1 d674389dex21.htm EX-2.1 609712
3 EX-2.2 d674389dex22.htm EX-2.2 53277
4 EX-2.3 d674389dex23.htm EX-2.3 49982
5 EX-2.4 d674389dex24.htm EX-2.4 20562
6 EX-2.5 d674389dex25.htm EX-2.5 20436
7 EX-99.1 d674389dex991.htm EX-99.1 25541
8 EX-99.2 d674389dex992.htm EX-99.2 35708
9 GRAPHIC g674389dsp38a.jpg GRAPHIC 6109
10 GRAPHIC g674389dsp39.jpg GRAPHIC 6777
  Complete submission text file 0001193125-19-002000.txt   876584
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 19508484
SIC: 2834 Pharmaceutical Preparations